Search

2023 - 2025 $120,000 Transplantation, Predictive Biomarkers Multiomic characterization of chronic, active T cell-mediated rejection in pediatric kidney transplant recipients Lay Abstract For children with end-stage kidney failure, a kidney transplant is life-saving. Although there has been...

While Tom has been a dedicated volunteer and donor for many years, he wanted to ensure The Foundation’s mission continues beyond his lifetime. The Kidney Foundation of Canada deeply appreciates the generosity and unwavering support of its donors. One notable donor, Tom Meade, shares a profound...

2022 - 2025 $100,000 Glomerulonephritis, Kidney Biology A novel mouse model of MCD driven by podocyte autoantigen and T/B crosstalk Lay Abstract Kidneys act as a barrier that filters water and waste products into urine while retaining important proteins in blood. When this filtration barrier is...

2024 - 2026 $120,000 Glomerulonephritis Role of the extrafollicular B cell response in the production of anti-podocyte antibodies in idiopathic nephrotic syndrome Lay Abstract Background: Kidneys act as a barrier that filters water and waste products into urine while retaining important proteins in...

2022 - 2024 $100,000 Transplantation Effects of prednisone avoidance or tapering on mycophenolate exposure in adult kidney transplant patients Lay Abstract Kidney transplant recipients need to take multiple anti-rejection medications to ensure their body does not reject the transplanted organ....

2025 - 2027 $120,000 Transplantation Model-informed precision dosing of mycophenolic acid in pediatric kidney transplant recipients Co-Applicant(s):  Chia Wei Teoh, Lorraine Hamiwka, Lusine Tonoyan, Michelle Ruhl, Tom Blydt-Hansen Lay Abstract BACKGROUND: The drug mycophenolic acid (MPA) is...

This year (2025) marks a huge milestone for the Canadian Institutes of Health Research (CIHR) as it celebrates its 25th anniversary. The Kidney Foundation of Canada is proud to have established a strong connection to CIHR from its inception to ensure a strong kidney-focus in Canada’s research...

Assistance to make travel a reality for individuals requiring hemodialysis The Travel Loan program is designed to help make travel more convenient and affordable for  Ontarians  on dialysis. Individuals who require dialysis cannot ignore their regular dialysis schedule even when travelling on...

The BC & Yukon Branch provides interest-free loans up to $1,000.00 which must be repaid. These loans are intended to cover "reimbursable costs" for hemodialysis treatments while traveling outside of Canada and for which the individual is eligible for reimbursement from the provincial Ministry of...

The Southern Alberta Branch's Hemodialysis Treatment Travel Loan is offered to help make travel more accessible for dialysis patients. Albertans must pay for dialysis treatments up-front when they travel to another country. The costs vary, depending on the dialysis centre you choose. After you...